266
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Assessing diversionary approaches for drug misusers in police custody in London: engagement and treatment outcomes as part of the Drug Intervention Programme

&
Pages 223-230 | Received 31 Jan 2020, Accepted 15 Jun 2020, Published online: 02 Jul 2020

References

  • Best D, Day E, Campbell A, Flynn PM, Simpson DD. 2009. Relationship between drug treatment engagement and criminal thinking style among drug-using offenders. Eur Addict Res. 15(2):71–77.
  • Best D, Walker D, Aston E, Pegram C, O'Donnell G. 2010. Assessing the impact of a high-intensity partnership between the police and drug treatment service in addressing the offending of problematic drug users. Policing Society. 20(3):358–369.
  • Boreham R, Cronberg A, Dollin L, Pudney S. 2007. The arrestee survey 2003–2006. Home Office Statistical Bulletin 12/07. London: Home Office.
  • Bosma A, Kunst M, Reef J, Dirkzwager A, Nieuwbeerta P. 2016. Prison-based rehabilitation: predictors of offender treatment participation and treatment completion. Crime Delinquency. 62(8):1095–1120.
  • Brocato JO, Wagner EF. 2008. Predictors of retention in an alternative-to-prison substance abuse treatment program. Crim Just Behav. 35(1):99–119.
  • Bull M. 2005. A comparative review of best practice guidelines for the diversion of drug related offenders. Int J Drug Policy. 16(4):223–234.
  • Clark CB, McCullumsmith CB, Redmond N, Hardy S, Waesche MC, Osula G, Cropsey KL. 2013. Factors associated with rapid failure in a Treatment Alternatives for Safer Communities (TASC) program. J Subst Abuse Treatment. 45(4):376–380.
  • Eastwood B, Strang J, Marsden J. 2018. Continuous opioid substitution treatment over five years: heroin use trajectories and outcomes. Drug Alcohol Depend. 188:200–208.
  • Edmunds M, Hough M, Turnbull PJ, May T. 1999. Doing justice to treatment: referring offenders to drug services. London: Home Office.
  • Edmunds M, May T, Hearnden I, Hough M. 1998. Arrest referral: emerging lessons from research. London: Central Drugs Prevention Unit, Home Office.
  • Evans E, Li L, Hser YI. 2009. Client and program factors associated with dropout from court mandated drug treatment. Eval Prog Plann. 32(3):204–212.
  • Godfrey C, Stewart D, Gossop M. 2004. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction. 99(6):697–707.
  • Godley SH, Finch M, Dougan L, McDonnell M, McDermeit M, Carey A. 2000. Case management for dually diagnosed individuals involved in the criminal justice system. J Subst Abuse Treat. 18(2):137–148.
  • Gossop M, Marsden J, Stewart D, Kidd T. 2003. The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction. 98(3):291–303.
  • Gossop M, Trakada K, Stewart D, Witton J. 2005. Reductions in criminal convictions after addiction treatment: 5-year follow-up. Drug Alcohol Depend. 79(3):295–302.
  • Green A, Pickering H, Foster R, Power R, Stimson GV. 1994. Who uses cocaine? Social profiles of cocaine users. Addict Res. 2(2):141–154.
  • Hancock J, Fearon C, McLaughlin H, Fielden B. 2012. Policing the “Drugs Intervention Programme” (DIP): an exploratory study of the Southern UK Policing Region. Policing. 6(4):431–442.
  • Hayhurst KP, Leitner M, Davies L, Flentje R, Millar T, Jones A, King C, Donmall M, Farrell M, Fazel S. 2015. The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation. Health Technol Assess. 19(6):1–168.
  • Hiller ML, Knight K, Leukefeld C, Simpson DD. 2002. Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment. Crim Just Behav. 29(1):56–75.
  • Holdsworth E, Bowen E, Brown S, Howat D. 2014. Offender engagement in group programs and associations with offender characteristics and treatment factors: a review. Aggress Viol Behav. 19(2):102–121.
  • Holloway KR, Bennett T, Farrington DP. 2008. Effectiveness of treatment in reducing drug-related crime: report prepared for The National Council for Crime Prevention, Sweden. Swedish National Council for Crime Prevention (BRÅ).
  • Home Office. 2009. Drug interventions programme operational handbook. London: Home Office.
  • Home Office/Ministry of Justice. 2010. Integrated offender management: key principles. London: Home Office.
  • Hunter G, McSweeney T, Turnbull PJ. 2005. The introduction of drug arrest referral schemes in London: a partnership between drug services and the police. Int J Drug Policy. 16(5):343–352.
  • Jones A, Hayhurst KP, Millar T, Pierce M, Dunn G, Donmall M. 2016. Short-term outcomes for opiate and crack users accessing treatment: the effects of criminal justice referral and crack use. Eur Addict Res. 22(3):145–152.
  • Kelly CE, Welsh WN. 2016. Examining treatment climate across prison-based substance abuse treatment groups. Subst Use Misuse. 51(7):902–911.
  • Kothari G, Marsden J, Strang J. 2002. Opportunities and obstacles for effective treatment of drug misusers in the criminal justice system in England and Wales. Br J Criminol. 42(2):412–432.
  • Kouimtsidis C, Edwards J, Wallis C, Drabble K. 2008. Drug Interventions Programme: clinical profile of service users v. attendees of standard services. Psychiatr Bull. 32(7):245–247.
  • Longshore D, Urada D, Evans E, Hser Y, Prendergast M, Hawken A, Bunch T, Ettner S. 2003. Evaluation of the Substance Abuse and Crime Prevention Act 2002 Report. Report Prepared for the Department of Alcohol and Drug Programs California Health and Human Services Agency. Los Angeles: University of California Los Angeles UCLA.
  • Marlowe DB. 2003. Integrating substance abuse treatment and criminal justice supervision. Sci Pract Perspect. 2(1):4–14.
  • Maume MO, Lanier C, DeVall K. 2018. The effect of treatment completion on recidivism among TASC program clients. Int J Offender Ther Comp Criminol. 62(15):4776–4795.
  • McSweeney T, Hughes C, Ritter A. 2018. The impact of compliance with a compulsory model of drug diversion on treatment engagement and reoffending. Drugs Educ Prev Policy. 25(1):56–66.
  • Mills H, Skodbo S, Blyth P. 2013. Understanding organised crime: estimating the scale and the social and economic costs. Home Office Research Report 73.
  • Morgan N. 2014. The heroin epidemic of the 1980s and 1990s and its effect on crime trends – then and now. Home Office Research Report 79.
  • Morgan N, Elliott A, Millar T, Heap D. 2016. New opiate and crack-cocaine users: characteristics and trends. Open Government Licence (OGL). London: Home Office.
  • Oerton J, Hunter G, Hickman M, Morgan D, Turnbull P, Kothari G, Marsden J. 2003. Arrest referral in London police stations: characteristics of the first year. A key point of intervention for drug users? Drugs Educ Prev Policy. 10(1):73–85.
  • Olver ME, Stockdale KC, Wormith JS. 2011. A meta-analysis of predictors of offender treatment attrition and its relationship to recidivism. J Consult Clin Psychol. 79(1):6–21.
  • Osborne A. 2013. Future delivery of the Drug Interventions Programme: do the benefits justify the costs? J Forensic Leg Med. 20(7):816–820.
  • Pierce M, Hayhurst K, Bird SM, Hickman M, Seddon T, Dunn G, Millar T. 2015. Quantifying crime associated with drug use among a large cohort of sanctioned offenders in England and Wales. Drug Alcohol Depend. 155:52–59.
  • Richardson E, McSherry B. 2010. Diversion down under—programs for offenders with mental illnesses in Australia. Int J Law Psychiatry. 33(4):249–257.
  • Ridgely MS, Willenbring ML. 1993. Application of case management to drug abuse treatment: overview of models and research issues. NIDA Res Monogr. 127:12.
  • Rosen PJ, Hiller ML, Webster JM, Staton M, Leukefeld C. 2004. Treatment motivation and therapeutic engagement in prison-based substance use treatment. J Psychoact Drugs. 36(3):387–396.
  • Scott DA, McGilloway S, Dempster M, Browne F, Donnelly M. 2013. Effectiveness of criminal justice liaison and diversion services for offenders with mental disorders: a review. Psychiatr Serv. 64(9):843–849.
  • Skodbo S, Brown G, Deacon S, Cooper A, Hall A, Millar T, Smith J, Whitham K. 2007. The Drug Interventions Programme (DIP): addressing drug use and offending through ‘Tough Choices’. London: Home Office.
  • Sondhi A, O'Shea J, Williams T. 2002. Arrest referral: emerging findings from the national monitoring and evaluation programme. London: Home Office.
  • Spooner C, Hall W, Mattick RP. 2001. An overview of diversion strategies for Australian drug-related offenders. Drug Alcohol Rev. 20(3):281–294.
  • Srivastava S, Forrester A, Davies S, Nadkarni R. 2013. Developing criminal justice liaison and diversion services: research priorities and international learning. Crim Behav Ment Health. 23(5):315–320.
  • Stewart MJ, Fulton, HG, Barrett SP. 2014. Powder and crack cocaine use among opioid users: is all cocaine the same? J Addict Med. 8(4):264–270.
  • Stewart D, Gossop M, Marsden J, Rolfe A. 2000. Drug misuse and acquisitive crime among clients recruited to the National Treatment Outcome Research Study (NTORS). Crim Behav Ment Health. 10(1):10–20.
  • Sturgess D, Woodhams J, Tonkin M. 2016. Treatment engagement from the perspective of the offender: reasons for noncompletion and completion of treatment—a systematic review. Int J Offender Ther Comp Criminol. 60(16):1873–1896.
  • Taylor LR, Caudy M, Blasko BL, Taxman FS. 2017. Differences by gender in predictors of motivation among substance abuse treatment participants. Subst Use Misuse. 52(4):468–476.
  • UK Drug Policy Commission (UKDPC). 2008. Reducing drug use, reducing reoffending. Are programmes for problem drug-using offenders in the UK supported by the evidence? London: UKDPC.
  • Ventura LA, Lambert EG. 2004. Recidivism 12 months after TASC. J Offend Rehabil. 39(1):63–82.
  • Welsh WN, McGrain PN. 2008. Predictors of therapeutic engagement in prison-based drug treatment. Drug Alcohol Depend. 96(3):271–280.
  • Yang Y, Perkins DR, Stearns AE. 2018. Barriers and facilitators to treatment engagement among clients in inpatient substance abuse treatment. Qual Health Res. 28(9):1474–1485.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.